Susanne B Haga1, Rachel Mills1, Jivan Moaddeb1. 1. Center for Applied Genomics & Precision Medicine, Duke University, School of Medicine, 304 Research Drive, Box 90141, Durham, NC 27708, USA.
Abstract
AIM: Over the past several decades, the roles and services of community pharmacists have expanded beyond traditional medical dispensation and compounding, and include health services such as vaccinations, and clinical testing and screening. Incorporating pharmacogenetic (PGx) testing into the menu of pharmacy services is logical and feasible; however, few pharmacists have experience with PGx testing, and few educational resources about PGx are available to support the uptake of PGx testing in community pharmacies. METHODS: We developed a toolkit of four resources to assist pharmacists to provide PGx testing. We conducted a survey of pharmacists in North Carolina to evaluate each component of the toolkit and the toolkit as a whole. RESULTS: A total of 380 respondents completed the evaluation of one or more toolkit components (344 evaluated all four components and the overall toolkit). Most respondents (84%) have never ordered or used PGx test results. Though the usability of the toolkit overall was below average (65.1 on a range of 0-100), individual components were perceived as useful and more than 75% of pharmacists reported that they would use the toolkit components when offering testing, with the result summary sheet receiving the highest score (4.01 out of 5). Open-text comments highlighted the need for more patient-friendly language and formatting. CONCLUSION: The majority of pharmacist respondents scored the components of the toolkit favorably. The next steps will be to revise and assess use of the toolkit in community pharmacy settings.
AIM: Over the past several decades, the roles and services of community pharmacists have expanded beyond traditional medical dispensation and compounding, and include health services such as vaccinations, and clinical testing and screening. Incorporating pharmacogenetic (PGx) testing into the menu of pharmacy services is logical and feasible; however, few pharmacists have experience with PGx testing, and few educational resources about PGx are available to support the uptake of PGx testing in community pharmacies. METHODS: We developed a toolkit of four resources to assist pharmacists to provide PGx testing. We conducted a survey of pharmacists in North Carolina to evaluate each component of the toolkit and the toolkit as a whole. RESULTS: A total of 380 respondents completed the evaluation of one or more toolkit components (344 evaluated all four components and the overall toolkit). Most respondents (84%) have never ordered or used PGx test results. Though the usability of the toolkit overall was below average (65.1 on a range of 0-100), individual components were perceived as useful and more than 75% of pharmacists reported that they would use the toolkit components when offering testing, with the result summary sheet receiving the highest score (4.01 out of 5). Open-text comments highlighted the need for more patient-friendly language and formatting. CONCLUSION: The majority of pharmacist respondents scored the components of the toolkit favorably. The next steps will be to revise and assess use of the toolkit in community pharmacy settings.
Entities:
Keywords:
community pharmacy; patient education; pharmacogenetic testing
Authors: G K Berland; M N Elliott; L S Morales; J I Algazy; R L Kravitz; M S Broder; D E Kanouse; J A Muñoz; J A Puyol; M Lara; K E Watkins; H Yang; E A McGlynn Journal: JAMA Date: 2001 May 23-30 Impact factor: 56.272
Authors: John E Murphy; James S Green; Laura A Adams; Robert B Squire; Grace M Kuo; Alan McKay Journal: Am J Pharm Educ Date: 2010-02-10 Impact factor: 2.047
Authors: Shanna K O'Connor; Stefanie P Ferreri; Natasha M Michaels; Rebecca W Chater; Anthony J Viera; Hawazin Faruki; Howard L McLeod; Mary Roederer Journal: J Am Pharm Assoc (2003) Date: 2012
Authors: Juliette Christie; Gwendolyn P Quinn; Teri Malo; Ji-Hyun Lee; Xiuhua Zhao; Jessica McIntyre; Jennifer Brzosowicz; Paul B Jacobsen; Susan T Vadaparampil Journal: Ann Surg Oncol Date: 2012-07-06 Impact factor: 5.344
Authors: Konstantinos Mitropoulos; Hayat Al Jaibeji; Diego A Forero; Paul Laissue; Ambroise Wonkam; Catalina Lopez-Correa; Zahurin Mohamed; Wasun Chantratita; Ming Ta Michael Lee; Adrian Llerena; Angela Brand; Bassam R Ali; George P Patrinos Journal: Hum Genomics Date: 2015-06-18 Impact factor: 4.639
Authors: Joseph O'Shea; Cristín Ryan; Joseph Gallagher; Claire O'Brien; Conor Morris; Eoin Dwyer; James Mc Laughlin; Laura Fitzpatrick; Maire O'Meara; Sarah Kelly; Sophie Knox; Mark Ledwidge Journal: Explor Res Clin Soc Pharm Date: 2022-09-21